These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19889218)

  • 1. Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro.
    Aljofan M; Sganga ML; Lo MK; Rootes CL; Porotto M; Meyer AG; Saubern S; Moscona A; Mungall BA
    Virol J; 2009 Nov; 6():187. PubMed ID: 19889218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Nipah virus and Hendra virus replication in different cell lines and their suitability for antiviral screening.
    Aljofan M; Saubern S; Meyer AG; Marsh G; Meers J; Mungall BA
    Virus Res; 2009 Jun; 142(1-2):92-9. PubMed ID: 19428741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.
    Elshabrawy HA; Fan J; Haddad CS; Ratia K; Broder CC; Caffrey M; Prabhakar BS
    J Virol; 2014 Apr; 88(8):4353-65. PubMed ID: 24501399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virus.
    Aljofan M; Porotto M; Moscona A; Mungall BA
    J Virol Methods; 2008 Apr; 149(1):12-9. PubMed ID: 18313148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy.
    Porotto M; Orefice G; Yokoyama CC; Mungall BA; Realubit R; Sganga ML; Aljofan M; Whitt M; Glickman F; Moscona A
    J Virol; 2009 May; 83(10):5148-55. PubMed ID: 19264786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed Molecular Biochemistry for Novel Therapeutic Design Against Nipah and Hendra Virus: A Systematic Review.
    Bhattacharya S; Dhar S; Banerjee A; Ray S
    Curr Mol Pharmacol; 2020; 13(2):108-125. PubMed ID: 31657692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developments towards effective treatments for Nipah and Hendra virus infection.
    Bossart KN; Broder CC
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):43-55. PubMed ID: 16441208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of gentian violet and brilliant green against some microorganisms associated with skin infections.
    Bakker P; Van Doorne H; Gooskens V; Wieringa NF
    Int J Dermatol; 1992 Mar; 31(3):210-3. PubMed ID: 1568820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors.
    Porotto M; Carta P; Deng Y; Kellogg GE; Whitt M; Lu M; Mungall BA; Moscona A
    J Virol; 2007 Oct; 81(19):10567-74. PubMed ID: 17652384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Containing the contagion: treating the virus that inspired the film.
    Lee B
    Sci Transl Med; 2011 Oct; 3(105):105fs6. PubMed ID: 22013121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections.
    Dang HV; Chan YP; Park YJ; Snijder J; Da Silva SC; Vu B; Yan L; Feng YR; Rockx B; Geisbert TW; Mire CE; Broder CC; Veesler D
    Nat Struct Mol Biol; 2019 Oct; 26(10):980-987. PubMed ID: 31570878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral entry inhibitors targeted to the membrane site of action.
    Porotto M; Yokoyama CC; Palermo LM; Mungall B; Aljofan M; Cortese R; Pessi A; Moscona A
    J Virol; 2010 Jul; 84(13):6760-8. PubMed ID: 20357085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virus.
    Tigabu B; Rasmussen L; White EL; Tower N; Saeed M; Bukreyev A; Rockx B; LeDuc JW; Noah JW
    Assay Drug Dev Technol; 2014 Apr; 12(3):155-61. PubMed ID: 24735442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainment.
    Talekar A; Pessi A; Glickman F; Sengupta U; Briese T; Whitt MA; Mathieu C; Horvat B; Moscona A; Porotto M
    PLoS One; 2012; 7(3):e30538. PubMed ID: 22396728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.
    Bossart KN; Mungall BA; Crameri G; Wang LF; Eaton BT; Broder CC
    Virol J; 2005 Jul; 2():57. PubMed ID: 16026621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favipiravir (T-705) protects against Nipah virus infection in the hamster model.
    Dawes BE; Kalveram B; Ikegami T; Juelich T; Smith JK; Zhang L; Park A; Lee B; Komeno T; Furuta Y; Freiberg AN
    Sci Rep; 2018 May; 8(1):7604. PubMed ID: 29765101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput virtual screening of Streptomyces spp. metabolites as antiviral inhibitors against the Nipah virus matrix protein.
    Macalalad MAB; Odchimar NMO; Orosco FL
    Comput Biol Chem; 2024 Oct; 112():108133. PubMed ID: 38968780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling.
    Rodriguez JJ; Horvath CM
    Viral Immunol; 2004; 17(2):210-9. PubMed ID: 15279700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate-dependent enhancement of henipavirus infection.
    Mathieu C; Dhondt KP; Châlons M; Mély S; Raoul H; Negre D; Cosset FL; Gerlier D; Vivès RR; Horvat B
    mBio; 2015 Mar; 6(2):e02427. PubMed ID: 25759505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity.
    Shih SR; Chu TY; Reddy GR; Tseng SN; Chen HL; Tang WF; Wu MS; Yeh JY; Chao YS; Hsu JT; Hsieh HP; Horng JT
    J Biomed Sci; 2010 Feb; 17(1):13. PubMed ID: 20178582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.